PRGO - Perrigo Company plc

NYSE - NYSE Delayed Price. Currency in USD
43.18
-0.83 (-1.89%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close44.01
Open44.09
Bid43.28 x 800
Ask43.29 x 1400
Day's Range42.96 - 44.09
52 Week Range36.28 - 80.66
Volume671,736
Avg. Volume1,211,926
Market Cap5.872B
Beta (3Y Monthly)1.88
PE Ratio (TTM)51.71
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.84 (2.00%)
Ex-Dividend Date2019-05-30
1y Target EstN/A
Trade prices are not sourced from all markets
  • Markit3 days ago

    See what the IHS Markit Score report has to say about Perrigo Company PLC.

    Perrigo Company PLC NYSE:PRGOView full report here! Summary * Bearish sentiment is moderate and increasing * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NeutralShort interest is moderate for PRGO with between 5 and 10% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on June 10. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold PRGO had net inflows of $2.26 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Why Is Perrigo (PRGO) Down 17.4% Since Last Earnings Report?
    Zacks8 days ago

    Why Is Perrigo (PRGO) Down 17.4% Since Last Earnings Report?

    Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Thomson Reuters StreetEvents24 days ago

    Edited Transcript of PRGO earnings conference call or presentation 9-May-19 12:00pm GMT

    Q1 2019 Perrigo Company PLC Earnings Call and Investor Day 2019

  • What Kind Of Investor Owns Most Of Perrigo Company plc (NYSE:PRGO)?
    Simply Wall St.last month

    What Kind Of Investor Owns Most Of Perrigo Company plc (NYSE:PRGO)?

    Every investor in Perrigo Company plc (NYSE:PRGO) should be aware of the most powerful shareholder groups. Large...

  • Reuterslast month

    US STOCKS-Wall St falls as weak economic data triggers growth worries

    U.S. stocks fell on Wednesday, as a clutch of weak economic data from the United States and China sparked worries of slowing global growth against the backdrop of a bitter trade dispute that has roiled financial markets. Domestic data showed retail sales unexpectedly fell in April as households cut back on purchases of motor vehicles and a range of other goods, and another report showed declining output of cars and machinery led to a surprise fall in U.S. factory production for April. Meanwhile data from China also showed surprisingly weak growth in retail sales and industrial output for April, adding pressure on the country to roll out more stimulus.

  • Reuterslast month

    US STOCKS-Wall St set to open lower after weak retail sales data

    Wall Street was set to open lower on Wednesday, as a surprise fall in domestic retail sales and underwhelming data from China raised growth concerns, while investors waited for more developments on the U.S.-China trade dispute. Government data showed U.S. retail sales unexpectedly fell in April as motor vehicle purchases slumped, while data from China also showed surprisingly weak growth in retail sales and industrial output for April, adding pressure on Beijing to roll out more stimulus. "The U.S. retail sales report is clearly disappointing.

  • Is Perrigo Company plc (PRGO) A Good Stock To Buy?
    Insider Monkeylast month

    Is Perrigo Company plc (PRGO) A Good Stock To Buy?

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 700 world-class investment firms that we track and now have access to the collective wisdom contained in […]

  • Barrons.comlast month

    It’s a Brutal Day for the Market but These 8 Stocks Are Thriving

    FEATURE The S&P 500 was getting hammered this morning amid continued trade fears. Many of the 500 stocks in the index were down Thursday morning, dragging the index down as low as 1.5%. But not every stock was losing.

  • Perrigo (PRGO) Beats on Q1 Earnings and Sales, Stock Up
    Zackslast month

    Perrigo (PRGO) Beats on Q1 Earnings and Sales, Stock Up

    Perrigo (PRGO) reports encouraging first-quarter 2019 results. The Rx segment recovers during the quarter on strong new product sales.

  • TheStreet.comlast month

    Perrigo Buys Oral Care Company Ranir for $750 Million as Part of New Strategy

    was gaining more than 5% Thursday after announcing the all-cash acquisition of privately-held Ranir Global Holdings in a deal valued at $750 million. Ranir is the largest private label oral care company in the world, according to Perrigo, with a portfolio of more than 300 oral care products including toothbrush heads and whitening strips. "The addition of Ranir to the Perrigo family illustrates a key component of our new strategy, accelerating growth by pursuing adjacent self-care categories.

  • MarketWatchlast month

    Perrigo to acquire Ranir Global Holdings in $750 million all-cash deal as part of transformation strategy

    Perrigo Co. said Thursday that it has reached an agreement to acquire privately-held oral care company Ranir Global Holdings LLC in a $750 million all-cash deal, or $685 million including cash tax benefits. The announcement is part of a transformation strategy that the self-care company unveiled during its investor day event. Ranir's portfolio includes more than 300 oral care items including manual toothbrushes, floss and dentures. The deal is expected to be about 10 cents per share accretive to 2019 adjusted earnings based on a third-quarter closing. The move is part of Perrigo's strategy to grow in self-care adjacent areas of business, according to a statement from Chief Executive Murray Kessler. Ranir has 650 employees and generated $287 million in net sales in 2018. Annual operating synergies between the two companies are expected to be about $10 million by 2021. The company also reaffirmed its plans to sell or spin off the generic pharmaceuticals business by the end of 2019 or in 2020; divest the animal health business through a $185 million cash deal with PetIQ Inc. ; investing more than $250 million in incremental capital over the next four years to expand the infant nutrition and tablet manufacturing businesses; and launching a cost savings program that will generate $100 million in annualized cost savings. Perrigo is also in discussions with several cannabidiol (CBD) companies to create products, among other innovations the company is pursuing. For 2019, Perrigo is guiding for sales between $4.6 billion and $4.7 billion, EPS between $1.24 and $1.54, and adjusted EPS of $3.65 to $3.95. The FactSet consensus is for sales of $4.7 billion and EPS of $4.14. Perrigo shares are up 27% for the year to date while the S&P 500 index has gained nearly 15%.

  • PetIQ, Inc. (PETQ) Q1 2019 Earnings Call Transcript
    Motley Foollast month

    PetIQ, Inc. (PETQ) Q1 2019 Earnings Call Transcript

    PETQ earnings call for the period ending March 31, 2019.

  • Perrigo (PRGO) Q1 Earnings and Revenues Top Estimates
    Zackslast month

    Perrigo (PRGO) Q1 Earnings and Revenues Top Estimates

    Perrigo (PRGO) delivered earnings and revenue surprises of 13.83% and 2.20%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Presslast month

    Perrigo: 1Q Earnings Snapshot

    The Dublin-based company said it had net income of 47 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.07 per share. The results beat Wall Street expectations. The average estimate ...

  • What's in the Cards for Perrigo (PRGO) This Earnings Season?
    Zackslast month

    What's in the Cards for Perrigo (PRGO) This Earnings Season?

    Perrigo (PRGO) is focused on Consumer Healthcare Americas segment. Let's see if it aids the company's results in the soon-to-be reported quarter.

  • TheStreet.com2 months ago

    IRS Has Wrong Prescription for Perrigo

    tumbled 7.3% to $47.67 Tuesday after the pharmaceutical company said it had received an $843 million bill from the Internal Revenue Service. The Dublin-based company said in a filing that it had gotten a revised Notice of Proposed Adjustment from the IRS examination team auditing Athena Neurosciences Inc. for the years ended Dec. 31, 2011 - 2013. Athena was acquired as a U.S. subsidiary by Elan Corp. in 1996 and Perrigo acquired Elan through a December 2013 business combination between Perrigo's predecessor and Elan.

  • MarketWatch2 months ago

    Perrigo will increase quarterly dividend by 11% to 21 cents per share

    Perrigo Company Plc announced Friday it would be increasing its quarterly dividend by 11% from 19 cents to 21 cents. The new dividend will be payable on June 18 to investors who own the stock at the close of business on May 31. This will be the sixteenth consecutive year the health company has increased its dividend. Shares of Perrigo have gained 29% in the year to date, while the S&P 500 has gained 16.7%.

  • Can Core Renal Care Unit Drive Baxter's (BAX) Q1 Earnings?
    Zacks2 months ago

    Can Core Renal Care Unit Drive Baxter's (BAX) Q1 Earnings?

    Strong performance across Renal Care, Clinical Nutrition, Advanced Surgery and Acute Therapies businesses might aid Baxter (BAX) in Q1. However, lower sales at Pharmaceutical business might be a woe.

  • 3 Medical Product Stocks Set to Beat This Earnings Season
    Zacks2 months ago

    3 Medical Product Stocks Set to Beat This Earnings Season

    The global medical device space takes significant strides in terms of research and development (R&D) and regulatory progress in the first quarter.

  • A Closer Look At Perrigo Company plc's (NYSE:PRGO) Uninspiring ROE
    Simply Wall St.2 months ago

    A Closer Look At Perrigo Company plc's (NYSE:PRGO) Uninspiring ROE

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. We'll use ROE to examine Perri...

  • Why Perrigo Company plc’s (NYSE:PRGO) High P/E Ratio Isn’t Necessarily A Bad Thing
    Simply Wall St.3 months ago

    Why Perrigo Company plc’s (NYSE:PRGO) High P/E Ratio Isn’t Necessarily A Bad Thing

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! This article is written for those who want to getRead More...